References: Pituitary tumor detailed guide

Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20004-2008. Central Brain Tumor Registry of the United States; 2012. Accessed at www.cbtrus.org/2012-NPCR-SEER/CBTRUS_Report_2004-2008_3-23-2012.pdf on September 26, 2012.

Feelders RA, de Bruin C, Pereira AM, et al. Pasireotide alone or with cabergoline and ketoconazole in Cushing’s disease. N Engl J Med. 2010;362:1846-1848.

Hornyak M, Couldwell WT. Multimodality treatment for invasive pituitary adenomas. Postgrad Med. 2009;121:168-176.

Klibanski A. Prolactinomas. N Engl J Med. 2010;362:1219-1226.

Lamberts SW, Hofland LJ. Future treatment strategies of aggressive pituitary tumors. Pituitary. 2009;12:261-264.

Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab. 2011;96:1992-2003.

Maity A, Pruitt AA, Judy KD, et al. Cancer of the central nervous system. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa. Elsevier; 2008:1075-1136.

National Cancer Institute. Physician Data Query (PDQ). Pituitary Tumors Treatment. 2012. Accessed at www.cancer.gov/cancertopics/pdq/treatment/pituitary/HealthProfessional on October 8, 2012.

Ragel BT, Couldwell WT. Pituitary carcinoma: A review of the literature. Neurosurg Focus. 2004;16: E7.

Tritos NA, Biller BM. Advances in medical therapies for Cushing’s syndrome. Discov Med. 2012;13:171-179.

Vierimaa O, Georgitsi M, Lehtonen R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science. 2006; 312:1228-1230.